Skip to main content

Table 1 Demographics and laboratory variables

From: Prognostic value of regional lymph node involvement in patients with metastatic colorectal cancer: palliative versus curative resection

 

LN− group

n = 167 (%)

LN+ group

n = 980 (%)

p value

Sex

 Male

93 (55.7)

556 (56.7)

0.801

 Female

74 (44.3)

424 (43.3)

Age (year)

62.0 ±15.1

61.7 ±14.2

0.776

 Age <50

35 (21)

192 (19.6)

0.682

 Age ≥50

132 (79)

788 (80.4)

BMIa

23.4 ±3.9

23.5 ±3.6

0.738

 <25

110 (66.7)

674 (69.6)

0.458

 ≥25

55 (33.3)

295 (30.4)

Family cancer history

 Yes

58 (34.9)

387 (40.2)

0.198

 No

108 (65.1)

575 (59.8)

Medical illness

 Hypertension

52 (31.1)

308 (31.4)

0.940

 Cardiac disease

10 (6)

73 (7.4)

0.501

 Diabetes mellitus

26 (15.6)

149 (15.2)

0.904

CEAa (ng/mL)

 CEA <5

48 (29.1)

263 (27.6)

0.687

 CEA ≥5

117 (70.9)

691 (72.4)

Hemoglobin (g/dL)

11.6 ± 2.4

11.6 ± 2.5

0.879

 ≥10

128 (76.6)

733 (74.8)

0.609

 <10

39 (23.4)

247 (25.2)

Albumina (g/dL)

3.9 ± 0.6

3.9 ± 0.6

0.793

 Albumin <3.5

29 (18)

161 (17.1)

0.775

 Albumin ≥3.5

132 (82)

781 (82.9)

 

Creatininea (mg/dL)

 Normal

138 (83.6)

793 (82.9)

0.807

 Abnormal

27 (16.4)

164 (17.1)

Total bilirubina (mg/dL)

 Normal

152 (98.7)

853 (96.4)

0.136

 Abnormal

2 (1.3%)

32 (3.6)

  1. CEA carcinoembryonic antigen
  2. aNumber of missing data: BMI 13, CEA 28, albumin 44, creatinine 25, total bilirubin 108